Performing routine abdominal and pelvic CTs does not increase detection of cancer among patients with unprovoked venous thromboembolism.
Routine screening with abdominal and pelvic CT for patients with unprovoked venous thromboembolism does not improve occult cancer detection, according to a study published in the New England Journal of Medicine.
Researchers from Canada performed a multicenter, open-label, randomized, controlled trial to assess the efficacy of a screening strategy for occult cancer that included comprehensive abdominal and pelvic CT in patients who had a first unprovoked venous thromboembolism.
“Unexplained blood clots have long been thought of as a possible early warning sign of cancer, with previous studies suggesting that up to 10 percent of patients with unexplained clots will be diagnosed with cancer within the year,” lead author Marc Carrier, MD, hematologist and senior scientist at The Ottawa Hospital, in Ontario Canada, and associate professor, University of Ottawa, said in a release. “Some clinical guidelines recommend a CT scan of the abdomen and pelvis in these patients, in addition to other cancer screening, but there has been very little evidence to know if the added CT scan is helpful. We did this study to find out.”
The researchers looked at 854 patients who presented with unexplained blood clots in the legs, lungs, or both. Patients were randomly assigned to undergo limited occult-cancer screening (basic blood testing, chest radiography, and screening for breast, cervical, and prostate cancer) or limited occult-cancer screening in combination with CT. The primary outcome measure was confirmed cancer that was missed by the screening strategy and detected by the end of the one-year follow-up period.[[{"type":"media","view_mode":"media_crop","fid":"39078","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_7520968416280","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3932","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Marc Carrier, MD","typeof":"foaf:Image"}}]]
The findings showed that 33 of the 854 patients (3.9%) were diagnosed with occult cancer between randomization and the one-year follow-up: 14 were from the 431 patients (3.2%) in the limited-screening group and 19 were among the 423 patients (4.5%) in the limited-screening-plus-CT group
The researchers calculated that four occult cancers (29%) were missed by the limited screening strategy and five (26%) were missed by the strategy of limited screening plus CT. The mean time to cancer diagnosis was 4.2 months in the limited-screening group and 4.0 months in the limited-screening-plus-CT group, which was not significant, the researchers said.
“Although it is tempting to believe that more cancer screening is always better, our study shows that this is not necessarily the case,” Carrier said in the release. “And in fact, unnecessary CT scanning has real risks. It can cause stress and anxiety in patients, as well as radiation exposure, and it can lead to over-investigation of false-positive findings. Our study means many patients will now be able to avoid this.”
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.